GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TYK Medicines 2410.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

3.52

+2.62%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

—

FY2022FY2025

Net income

−CN¥292.0m

FY2022FY2025

Free cash flow

−CN¥255.2m

FY2022FY2025

Shareholders' equity

CN¥286.8m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2023FY2022
Revenue——CN¥37.9m
Gross profit−CN¥24.4m−CN¥23.7mCN¥17.2m
Research and developmentCN¥221.6mCN¥213.6mCN¥197.0m
Operating income−CN¥314.2m−CN¥309.9m−CN¥255.7m
Net income−CN¥292.0m−CN¥327.8m−CN¥266.5m
Diluted earnings per share-0.77-0.88-0.72

Balance sheet

At each fiscal year end

FY2025FY2023FY2022
Total assetsCN¥780.1mCN¥491.2mCN¥478.6m
Cash and short-term investmentsCN¥367.4mCN¥165.3mCN¥208.7m
Total liabilitiesCN¥493.1mCN¥1.25bnCN¥907.7m
DebtCN¥152.8mCN¥1.14bnCN¥70.6m
Shareholders' equityCN¥286.8m−CN¥758.1m−CN¥433.6m
Shares outstanding378m371m371m

Cash flow

Fiscal years

FY2025FY2023FY2022
Cash from operations−CN¥215.8m−CN¥172.2m−CN¥188.6m
Capital spending−CN¥39.4m−CN¥66.2m−CN¥75.6m
Free cash flow−CN¥255.2m−CN¥238.4m−CN¥264.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Dec 2024Jun 2024Mar 2024
Revenue—————CN¥91,706——
Gross profit—————CN¥11,999−CN¥6.8m−CN¥6.8m
Operating income−CN¥78.7m−CN¥78.7m−CN¥97.5m−CN¥97.5m−CN¥106.7m−CN¥321.5m−CN¥80.0m−CN¥64.0m
Net income−CN¥12.4m−CN¥12.4m−CN¥93.8m−CN¥93.8m−CN¥112.2m−CN¥331.6m−CN¥95.6m−CN¥92.2m
Diluted earnings per share-0.03-0.03-0.25-0.25-0.30-0.89-0.26-0.25
Cash from operations−CN¥45.0m−CN¥45.0m−CN¥60.0m−CN¥60.0m−CN¥94.0m−CN¥264.0m−CN¥44.0m−CN¥71.0m
Capital spending−CN¥8.0m−CN¥8.0m−CN¥19.0m−CN¥19.0m—−CN¥63.0m—−CN¥15.0m
Free cash flow−CN¥53.0m−CN¥53.0m−CN¥79.0m−CN¥79.0m—−CN¥327.0m—−CN¥86.0m
Total assetsCN¥768.6mCN¥768.6mCN¥779.7mCN¥779.7mCN¥794.4mCN¥784.8mCN¥453.6mCN¥516.8m
Cash and short-term investmentsCN¥202.0mCN¥202.0mCN¥367.4mCN¥367.3mCN¥367.9mCN¥394.6mCN¥135.7mCN¥182.1m
DebtCN¥97.0mCN¥97.0mCN¥149.0mCN¥149.0mCN¥169.9mCN¥129.1mCN¥103.5mCN¥104.0m
Shareholders' equityCN¥261.0mCN¥261.0mCN¥286.7mCN¥286.7mCN¥356.9mCN¥402.0m−CN¥896.9m−CN¥804.7m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income7.1%——
Net income3.1%——

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings-14.7-47.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.